Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 04 Jul 2026 · HPRA open data

RPH Pharmaceuticals AB — Licensed Medicines

8 medicines held by RPH Pharmaceuticals AB on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

← All medicines · 8 products held by RPH Pharmaceuticals AB

Medicine	Active substance	Licence holder	Status
Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution PA1638/001/001	BETAMETHASONE SODIUM PHOSPHATE	RPH Pharmaceuticals AB	Marketed
Betnesol-N 0.1% w/v, 3500 IU/ml Eye, Ear and Nasal Drops, solution PA1638/002/001	Neomycin sulfate, BETAMETHASONE SODIUM PHOSPHATE	RPH Pharmaceuticals AB	Marketed
Bettamousse 1 mg/g (0.1%) cutaneous foam PA1638/009/001	Betamethasone valerate	RPH Pharmaceuticals AB	Marketed
Cocois Ointment, coal tar 12.0% sulphur for external use 4.0%, salicylic acid 2.0% PA1638/005/001	Coal tar solution, Sulphur for external use, Salicylic acid	RPH Pharmaceuticals AB	Marketed
Neo-Cytamen 1000 micrograms/ml Solution for Injection PA1638/004/001	Hydroxocobalamin	RPH Pharmaceuticals AB	Marketed
Trandate 100mg Film-Coated Tablets PA1638/006/002	Labetalol hydrochloride	RPH Pharmaceuticals AB	Marketed
Trandate 200mg Film-coated Tablets PA1638/006/003	Labetalol hydrochloride	RPH Pharmaceuticals AB	Marketed
Trandate 5 mg/ml Solution for Injection PA1638/006/001	Labetalol hydrochloride	RPH Pharmaceuticals AB	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.